A detailed history of Los Angeles Capital Management LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 330,291 shares of ORGO stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
330,291
Previous 368,591 10.39%
Holding current value
$1.32 Million
Previous $1.03 Million 8.53%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$2.42 - $3.24 $92,686 - $124,092
-38,300 Reduced 10.39%
330,291 $944,000
Q2 2024

Aug 05, 2024

SELL
$2.28 - $3.03 $300,905 - $399,887
-131,976 Reduced 26.37%
368,591 $1.03 Million
Q1 2024

Apr 05, 2024

BUY
$2.61 - $4.49 $411,270 - $707,511
157,575 Added 45.94%
500,567 $1.42 Million
Q4 2023

Feb 06, 2024

SELL
$1.97 - $4.21 $104,469 - $223,256
-53,030 Reduced 13.39%
342,992 $1.4 Million
Q3 2023

Nov 06, 2023

SELL
$2.34 - $4.43 $341,527 - $646,567
-145,952 Reduced 26.93%
396,022 $1.26 Million
Q2 2023

Aug 03, 2023

BUY
$1.9 - $4.3 $73,436 - $166,199
38,651 Added 7.68%
541,974 $1.8 Million
Q1 2023

May 04, 2023

BUY
$1.89 - $2.93 $221,271 - $343,029
117,075 Added 30.31%
503,323 $1.07 Million
Q4 2022

Feb 06, 2023

SELL
$2.48 - $3.43 $130,584 - $180,606
-52,655 Reduced 12.0%
386,248 $1.04 Million
Q3 2022

Nov 02, 2022

SELL
$3.14 - $6.43 $22,626 - $46,334
-7,206 Reduced 1.62%
438,903 $1.42 Million
Q2 2022

Aug 05, 2022

BUY
$4.74 - $8.15 $1.49 Million - $2.56 Million
314,414 Added 238.74%
446,109 $2.18 Million
Q1 2022

May 06, 2022

BUY
$6.47 - $9.57 $414,882 - $613,666
64,124 Added 94.9%
131,695 $1 Million
Q4 2021

Feb 03, 2022

BUY
$9.02 - $13.5 $609,490 - $912,208
67,571 New
67,571 $624,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $525M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.